Pretreatment clinical and hematologic prognostic factors of metastatic urothelial carcinoma treated with pembrolizumab: a systematic review and meta-analysis.
Yanagisawa T, Mori K, Katayama S, Mostafaei H, Quhal F, Laukhtina E, Rajwa P, Motlagh RS, Aydh A, König F, Grossmann NC, Pradere B, Miki J, Kimura T, Egawa S, Shariat SF.
Yanagisawa T, et al. Among authors: egawa s.
Int J Clin Oncol. 2022 Jan;27(1):59-71. doi: 10.1007/s10147-021-02061-0. Epub 2021 Nov 10.
Int J Clin Oncol. 2022.
PMID: 34757531
Free PMC article.
Review.